Lamb J R, Lathigra R, Rothbard J B, Sweetser D, Young R A, Ivanyi J, Young D B
Medical Research Council Tuberculosis and Related Infections Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S443-7. doi: 10.1093/clinids/11.supplement_2.s443.
The development of vaccines capable of inducing protective immunity against mycobacterial infection depends in part on the identification of antigenic determinants that activate T cells with antimycobacterial effector function. Various approaches designed to analyze the recognition of mycobacterial antigens by T cells are reviewed. In addition to the established approach of using serologically defined antigens, alternative methods independent of antibody preselection, such as polyacrylamide gel electrophoresis-fractionated immunoblots of mycobacteria, can be used to probe the specificity of the T cell repertoire. Furthermore, the application of recombinant DNA expression combined with that of synthetic peptides whose sequences are predicted to constitute T cell determinants allow the localization of T cell epitopes within a protein. The use of these techniques in defining potentially "pathogenic and protective" T cell epitopes in mycobacteria is discussed.
能够诱导针对分枝杆菌感染产生保护性免疫的疫苗开发,部分取决于对抗原决定簇的识别,这些抗原决定簇可激活具有抗分枝杆菌效应功能的T细胞。本文综述了旨在分析T细胞对分枝杆菌抗原识别的各种方法。除了使用血清学定义抗原的既定方法外,还可以使用独立于抗体预选的替代方法,如分枝杆菌的聚丙烯酰胺凝胶电泳分离免疫印迹,来探测T细胞库的特异性。此外,重组DNA表达与预测其序列构成T细胞决定簇的合成肽的应用相结合,可将T细胞表位定位在蛋白质内。本文还讨论了这些技术在确定分枝杆菌中潜在的“致病和保护”T细胞表位方面的应用。